|
Symbol Name ID |
Pld1
phospholipase D1 MGI:109585 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Pld1tm1.1Gdp/Pld1tm1.1Gdp involves: 129/SvJ * C57BL/6 |
abnormal autophagy | J:207283 |
| normal homeostasis/metabolism phenotype | J:207283 | |
| Pld1tm1.1Mafr/Pld1tm1.1Mafr B6.Cg-Pld1tm1.1Mafr |
abnormal platelet physiology | J:193451 |
| abnormal tumor vascularization | J:193451 | |
| decreased angiogenesis | J:193451 | |
| decreased metastatic potential | J:193451 | |
| decreased tumor growth/size | J:193451 | |
| Pld1tm1.1Mafr/Pld1tm1.1Mafr Not Specified |
no abnormal phenotype detected | J:192844 |
| Pld1tm3Mafr/Pld1tm3Mafr B6.129-Pld1tm3Mafr |
abnormal platelet activation | J:216114 |
| Pld1tm3Mafr/Pld1tm3Mafr involves: 129S1/Sv * 129X1/SvJ * C57BL/6 |
decreased cerebral infarct size | J:211547 |
| decreased platelet aggregation | J:211547 | |
| decreased susceptibility to induced morbidity/mortality | J:211547 | |
| decreased susceptibility to injury | J:211547 | |
| decreased susceptibility to ischemic brain injury | J:211547 | |
| increased mean platelet volume | J:211547 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 01/20/2026 MGI 6.24 |
|
|
|
||